SuperworthPropanc Biopharma shares outstanding PPCB
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 2.6M
- On a year earlier
- +454.9%
- more shares
Propanc Biopharma had 2.6M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 454.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 2.6M | +455% |
| FY2025 | 465.6K | +282512% |
| FY2024 | 165 | +6737% |
| FY2023 | 2 | +49739% |
| FY2021 | 0 | +866222% |
| FY2019 | 0 | +971% |
| FY2018 | 0 | +879% |
| FY2017 | 0 | +45% |
| FY2016 | 0 | +104% |
| FY2015 | 0 | +366% |
| FY2014 | 0 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 2.6M | +455% | |
| Q3 FY26 | 897.1K | +418% | |
| Q2 FY26 | 534.4K | +100000% | |
| Q1 FY26 | 493.3K | +125106% | |
| Q4 FY25 | 465.6K | +282512% | |
| Q3 FY25 | 173K | +435111% | |
| Q2 FY25 | 534 | +3262% | |
| Q1 FY25 | 394 | +5277% | |
| Q4 FY24 | 165 | +6737% | |
| Q3 FY24 | 40 | +3000% | |
| Q2 FY24 | 16 | +2380% | |
| Q1 FY24 | 7 | +2221% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Propanc Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.